【レポートの概要（一部）】
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. MARKET DEFINITION AND SCOPE
2.2. KEY FINDINGS
2.3. PARAMETRIC ANALYSIS
2.3.1. PREVALENCE & INCIDENCE RATE OF ALZHEIMER’S DISEASE
2.3.2. HOSPITAL AND RESEARCH CENTER ACROSS GEOGRAPHIES
2.3.3. PREVALENCE & INCIDENCE RATE OF PARKINSON’S DISEASE
2.3.4. PREVALENCE & INCIDENCE RATE OF CANCER DISEASE
2.3.5. HEALTHCARE EXPENDITURE ACROSS GEOGRAPHIES
2.4. KEY MARKET INSIGHTS
2.4.1. TOP 3 EMERGING COUNTRIES
2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
2.4.4. TOP 3 GEOGRAPHY
2.5. COMPETITIVE LANDSCAPE
2.5.1. MARKET SHARE ANALYSIS
2.5.2. TOP WINNING STRATEGIES
2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
2.6. PORTER’S FIVE FORCE MODEL
2.6.1. THREAT OF NEW ENTRANTS
2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
2.6.3. BARGAINING POWER OF BUYER
2.6.4. BARGAINING POWER OF SUPPLIER
2.6.5. INTENSITY OF COMPETITIVE RIVALRY
2.7. KEY BUYING CRITERIA
2.8. STRATEGIC RECOMMENDATION
2.9. STRATEGIC CONCLUSIONS
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. DEVELOPMENT IN PROTEOMICS, GENOMICS AND IMAGING SYSTEM HAS INCREASED DEMAND FOR CNS BIOMARKER.
3.1.2. FUNDING FROM GOVERNMENT AND PRIVATE PLAYERS TO BOOST CNS BIOMARKER MARKET
3.1.3. GROWTH IN LIFE STYLE ORIENTED DISEASES
3.1.4. GROWTH IN GOVERNMENT AND PRIVATE FUNDING IN CNS BIOMARKER MARKET
3.1.5. GROWTH IN PUBLIC-PRIVATE PARTNERSHIP
3.1.6. FDA APPROVALS GIVING RISE TO SIGNIFICANT SCOPE IN BIOMARKER MARKET
3.1.7. TECHNOLOGICAL ADVANCEMENT ENABLES TO EXPAND CNS BIOMARKER MARKET
3.1.8. INNOVATION GIVING RISE TO GROWTH OF CNS BIOMARKER MARKET
3.1.9. GLOBAL INCREASE IN HEALTHCARE EXPENDITURE
3.2. MARKET RESTRAINTS
3.2.1. HIGH COST OF CNS BIOMARKER TEST AND DIAGNOSTICS
3.2.2. REIMBURSEMENT ISSUES AFFECTING THE CNS BIOMARKER MARKET
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING ADOPTION OF PERSONALIZED MEDICINES
3.3.2. UNTAPPED APAC REGION HAS HUGE SCOPE FOR CNS BIOMARKER MARKET
3.3.3. GLOBAL INCREASE IN AGING POPULATION HAS CREATED HUGE SCOPE FOR CNS BIOMARKER MARKET
3.3.4. FAVORABLE GOVERNMENT POLICIES AND SUPPORT FOR CNS BIOMARKERS
3.4. MARKET CHALLENGES
3.4.1. CREATING AWARENESS FOR CNS BIOMARKER MARKET
3.4.2. GLOBAL ECONOMIC SLOWDOWN MAY AFFECT THE CNS BIOMARKER MARKET
3.4.3. TECHNICAL ISSUES OF SAMPLE COLLECTION AND STORAGE
3.5. PARENT MARKET
3.6. COMPETITORS MARKET
3.7. ALTERNATIVE MARKET
4. MARKET SEGMENTATION
4.1. GLOBAL CNS BIOMARKER MARKET BY APPLICATION, 2014-2022,($ MILLIONS)
4.1.1. GLOBAL DIAGNOSTIC DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
4.1.2. GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
4.1.3. GLOBAL PERSONALIZED MEDICINE MARKET, 2014-2022,($ MILLIONS)
4.1.4. GLOBAL DISEASE RISK ASSESSMENT MARKET, 2014-2022,($ MILLIONS)
4.1.5. GLOBAL OTHER MARKET , 2014-2022,($ MILLIONS)
4.2. GLOBAL CNS BIOMARKER MARKET BY TYPE, 2014-2022,($ MILLIONS)
4.2.1. GLOBAL SAFETY BIOMARKER MARKET , 2014-2022,($ MILLIONS)
4.2.2. GLOBAL EFFICACY BIOMARKER MARKET, 2014-2022,($ MILLIONS
4.2.3. GLOBAL PREDICTIVE BIOMARKER MARKET, 2014-2022,($ MILLIONS)
4.2.4. GLOBAL PHARMACODYNAMIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
4.2.5. GLOBAL PROGNOSTIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
4.2.6. GLOBAL VALIDATION BIOMARKER MARKET, 2014-2022,($ MILLIONS)
4.3. GLOBAL CNS BIOMARKER MARKET BY END USERS, 2014-2022,($ MILLIONS)
4.3.1. GLOBAL CNS BIOMARKER MARKET BY HOSPITALS, 2014-2022,($MILLIONS)
4.3.2. GLOBAL CNS BIOMARKER MARKET BY EYE CLINICS, 2014-2022,($MILLIONS)
4.3.3. GLOBAL CNS BIOMARKER MARKET BY DIAGNOSTIC CENTERS, 2014-2022,($MILLIONS)
4.3.4. GLOBAL CNS BIOMARKER MARKET BY PATIENTS, 2014-2022,($MILLIONS)
5. GEOGRAPHICAL ANALYSIS
5.1. NORTH AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.1.1. UNITED STATES (U.S.) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.1.2. CANADA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2. EUROPE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.1. UNITED KINGDOM (UK) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.2. FRANCE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.3. GERMANY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.4. SPAIN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.5. ITALY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.6. ROE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.3. ASIA PACIFIC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.3.1. INDIA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.3.2. CHINA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.3.3. JAPAN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.3.4. ROAPAC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.4. REST OF THE WORLD CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.4.1. LATIN AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.4.2. MENA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.4.3. AFRICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
6. COMPANY PROFILING: – (OVER, SCOT ANALYSIS, STRATEGIC REVIEW)
1. ABASTAR MDX INC
2. ABIANT INC
3. ACUMEN PHARMACEUTICALS INC
4. ADLYFE INC
5. ALSERES PHARMACEUTICALS INC
6. APITOPE INTERNATIONAL
7. APOSENSE
8. APPLIED NEUROSOLUTIONS INC
9. AVACTA GROUP PLC
10. AVID RADIOPHARMACEUTICALS INC
11. BANYAN BIOMARKERS
12. DIAGENIC ASA
13. EKFDIAGNOSTICS HOLDINGS INC
14. ENZO BIOCHEM INC
15. EXONHIT THERAPEUTICS
16. GENENEWS LTD
17. GLYCOMINDS LTD
18. GREAT LAKES NEUROTECHNOLOGIES
19. INNOGENETICS BIOLOGICALS
20. INNOVATIVE NEUROTECHNOLOGIES INC
21. MERC & CO. IN
22. METABOLON INC
23. MYRIAD RBM INC
24. OLIGOMERIX INC
25. OPKO HEALTH INC
26. OSTA BIOTECHNOLOGIES INC
27. PROTEOME SCIENCES PRODUCTS
28. PSYNOVA NEUROTECH LTD
29. RIDGE DIAGNOSTICS
30. SABIOSCIENCES
31. SATORI PHARMACEUTICAL INC
32. THERMO FISHER SCIENTIFIC
LIST OF TABLES
1. GLOBAL DIAGNOSTIC DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
2. GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
3. GLOBAL PERSONALIZED MEDICINE MARKET, 2014-2022,($ MILLIONS)
4. GLOBAL DISEASE RISK ASSESSMENT MARKET, 2014-2022,($ MILLIONS)
5. GLOBAL OTHER MARKET , 2014-2022,($ MILLIONS)
6. GLOBAL SAFETY BIOMARKER MARKET , 2014-2022,($ MILLIONS)
7. GLOBAL EFFICACY BIOMARKER MARKET, 2014-2022,($ MILLIONS
8. GLOBAL PREDICTIVE BIOMARKER MARKET, 2014-2022,($ MILLIONS)
9. GLOBAL PHARMACODYNAMIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
10. GLOBAL PROGNOSTIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
11. GLOBAL VALIDATION BIOMARKER MARKET, 2014-2022,($ MILLIONS)
12. GLOBAL CNS BIOMARKER MARKET BY HOSPITALS, 2014-2022,($MILLIONS)
13. GLOBAL CNS BIOMARKER MARKET BY EYE CLINICS, 2014-2022,($MILLIONS)
14. GLOBAL CNS BIOMARKER MARKET BY DIAGNOSTIC CENTERS, 2014-2022,($MILLIONS)
15. GLOBAL CNS BIOMARKER MARKET BY PATIENTS, 2014-2022,($MILLIONS)
16. NORTH AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
17. UNITED STATES (U.S.) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
18. CANADA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
19. EUROPE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
20. UNITED KINGDOM (UK) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
21. FRANCE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
22. GERMANY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
23. SPAIN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
24. ITALY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
25. ROE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
26. ASIA PACIFIC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
27. INDIA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
28. CHINA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
29. JAPAN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
30. ROAPAC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
31. REST OF THE WORLD CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
32. LATIN AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
33. MENA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
34. AFRICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
LIST OF FIGURES
1. GLOBAL DIAGNOSTIC DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
2. GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
3. GLOBAL PERSONALIZED MEDICINE MARKET, 2014-2022,($ MILLIONS)
4. GLOBAL DISEASE RISK ASSESSMENT MARKET, 2014-2022,($ MILLIONS)
5. GLOBAL OTHER MARKET , 2014-2022,($ MILLIONS)
6. GLOBAL SAFETY BIOMARKER MARKET , 2014-2022,($ MILLIONS)
7. GLOBAL EFFICACY BIOMARKER MARKET, 2014-2022,($ MILLIONS
8. GLOBAL PREDICTIVE BIOMARKER MARKET, 2014-2022,($ MILLIONS)
9. GLOBAL PHARMACODYNAMIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
10. GLOBAL PROGNOSTIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
11. GLOBAL VALIDATION BIOMARKER MARKET, 2014-2022,($ MILLIONS)
12. GLOBAL CNS BIOMARKER MARKET BY HOSPITALS, 2014-2022,($MILLIONS)
13. GLOBAL CNS BIOMARKER MARKET BY EYE CLINICS, 2014-2022,($MILLIONS)
14. GLOBAL CNS BIOMARKER MARKET BY DIAGNOSTIC CENTERS, 2014-2022,($MILLIONS)
15. GLOBAL CNS BIOMARKER MARKET BY PATIENTS, 2014-2022,($MILLIONS)
16. NORTH AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
17. UNITED STATES (U.S.) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
18. CANADA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
19. EUROPE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
20. UNITED KINGDOM (UK) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
21. FRANCE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
22. GERMANY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
23. SPAIN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
24. ITALY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
25. ROE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
26. ASIA PACIFIC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
27. INDIA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
28. CHINA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
29. JAPAN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
30. ROAPAC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
31. REST OF THE WORLD CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
32. LATIN AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
33. MENA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
34. AFRICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
【レポート販売概要】
■ タイトル：中枢神経系（CNS）バイオマーカーの世界市場：インサイト、市場機会、市場シェア、市場予測■ 英文：Global Central Nervous System (CNS) Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
■ 発行日：2016年5月
■ 調査会社：Occams Research
■ 商品コード：OCCAM60703
■ 調査対象地域：グローバル
- 急性喘息(Acute Asthma)：世界の治験レビュー2014年下半期版Acute Asthma Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Acute Asthma Global Clinical Trials Review, H2, 2014" provides data on the Acute Asthma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Asthma. It includes an overview of the trial numbers and their recruitment status as per the sit …
- 海軍ISRの世界市場ABSTRACTAbout Naval ISR The global naval ISR market is gaining momentum due to increasing maritime tensions and rapid development of high-end naval vessels by countries. As modern combats involve a greater emphasis on surveillance and intelligence and information gathering with respect to enemy movement, armed forces are largely focusing on the incorporation and integration of sophisticated and ad …
- 世界の教育関連技術及びスマート教室市場In recent times, there has been a significant growth in Smart Classrooms. A smart classroom is equipped with multimedia components which are designed to enrich the teaching and learning process. Technology in education has played a significant role in educating and connecting the students to the existing and future learning opportunities. Smart Classrooms have been enhanced with advanced technolog …
- コールドエンド排気装置のアフターマーケットの世界市場分析：システム別（ベーシック、パフォーマンス）、車両別（乗用車、商用車）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中東･アフリカ）、セグメント予測、2014-2025The global cold-end exhaust system aftermarket is expected to reach USD 6.04 billion by 2025, according to a new report by Grand View Research, Inc. Stringent government regulations & emission norms, complemented by sophisticated technology incorporations in the automobile exhaust component fabrication, are expected to boost the market growth. The increasing acceptance of electric vehicles as well …
- 蓄熱の世界市場予測（～2022年）：蓄熱技術（顕熱蓄熱、潜熱蓄熱、熱化学式蓄熱技術）、蓄熱材料、用途、エンドユーザー、地域別分析The global thermal energy storage market is projected to grow at a CAGR of 11.0% from 2017 to 2022, to reach a market size of USD 6.20 Billion by 2022. The growth is attributed to rising impetus on renewable energy generation such as concentrated solar power, increasing demand for thermal energy storage systems in HVAC, and government incentives for thermal energy storage systems. The report segme …
- Mitsui & Co., Ltd.：石油・ガスバリューチェーン分析レポート2013Mitsui & Co., Ltd. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Mitsui & Co., Ltd." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Mitsui & Co., Ltd.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines t …
- ビタミン成分の世界市場：ビタミンB、ビタミンC、ビタミンK、ビタミンD、ビタミンE、ビタミンAAbout Vitamins Vitamins are organic compounds that are required by living organisms in minute quantities to maintain a normal metabolic activity. These compounds usually cannot be synthesized by the organism and have to be obtained through external sources. The term “vitamin” is a generic descriptor for a group of chemical compounds or ingredients that have similar molecular structure and have the …
- ベビー用おしりふきの世界市場2015-2019About Baby Wipes Baby wipes are made from non-woven fabrics and are saturated with a solution of gentle cleansing ingredients. They are typically sold in plastic tubs that keep them moist and allow for easy dispensing. TechNavio's analysts forecast the Global Baby Wipes market to grow at a CAGR of 5.4 percent during the period 2014-2019. [Covered in this Report] This report covers the present scen …
- 没入型シミュレータの世界市場予測（～2022）：トレーニング、緊急サービス、製品開発The immersive simulator market is estimated to be worth USD 11.44 Billion by 2022, at a CAGR of 35.13% between 2016 and 2022. The growth of this market is majorly driven by the increasing applications in the medical industry, risk mitigation in oil and gas industries through training in immersive simulator, and ability to transfer knowledge quickly through training in immersive simulator The immer …
- 鉛蓄電池の世界市場予測（～2024年）“The global lead acid battery market is projected to grow at a CAGR of about 4 - 5% from 2019 to 2024” The global lead acid battery market is projected to reach USD 52.5 billion by 2024 from an estimated USD 41.6 billion in 2019, at a CAGR of 4.7% during the forecast period. This growth can be attributed to factors such as the basic requirement of cost-effective battery storage solutions in the de …
- 乾癬市場：日本の治療薬市場Psoriasis - Japan Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and personal angst for p …
- MaaS（サービスとしてのモビリティ）の世界市場予測（～2030年）“The rapid development of public transport infrastructure and the need to manage the rising traffic congestion to drive the Mobility as a Service (MaaS) market”The MaaS market is projected to grow to USD 106.8 billion by 2030 from USD 6.8 billion in 2020, at a CAGR of 31.7% during the forecast period. The increase in traffic congestion has led to the rapid development of public transport infrastru …
- 人工採油法の世界市場：ロッドリフト、電動ポンプ（ESP）、PCポンプ、ガスリフトThis report provides a detailed analysis of the artificial lift market, which is growing in sync with the need for higher production from maturing fields, better recovery rates, and increasing unconventional production activities. The market has been regionally segmented into Asia-Pacific, North America, Europe, the Middle East & Africa, and South & Central America. The market has been further seg …
- ポリウレタンフォーム発泡剤の世界市場2019-2023About this market The growing demand for PU foams in emerging economies such as India, China, Malaysia, Russia, and Brazil is attributed to the economic and industrial development in these countries. PU foams are used in industries such as the construction, automotive, electrical and electronics, paper manufacturing, paints and coatings, and oil and gas. The rise in demand for PU foams, the demand …
- 食品用増粘剤の世界市場予測（～2022年）：親水コロイド、タンパク質、澱粉“The food thickeners market projected to grow at a CAGR of 5.95%”The food thickeners market is projected to reach 15.80 billion by 2022 at a CAGR of 5.95% from 2016 to 2022. The market is driven by factors such as growth in demand for convenience foods, consumer awareness toward healthy diet, and multiple functionalities and advantages associated with the use of food thickeners. High R&D costs ass …
